EUVIMED · CrossrefZeitschrift
Amyloid
ISSN 1350-6129 · Informa UK Limited
Neueste Artikel
Effect of albumin in patients receiving hemodialysis on β 2 -microglobulin amyloid fibril formation
Longitudinal changes in gastrointestinal amyloid deposition before and after patisiran treatment in Hereditary ATTR amyloidosis
Amyloid nomenclature 2026: update, novel proteins, and discussion of intracellular aggregates and toxicity. Recommendations by the International Society of Amyloidosis Nomenclature Committee
Operational definitions of the asymptomatic TTR variant carrier: a methodological framework for ATTRv amyloidosis polyneuropathy research
Robert A. Kyle: In Memoriam
Ixazomib maintenance for the treatment of light chain AL amyloidosis
Prevalence and prognostic impact of valvular heart disease in transthyretin cardiac amyloidosis
Quality standards for the diagnosis and management of ATTR and AL amyloidosis: a nominal group technique study
Selective cellular vulnerability and resilience in amyloidosis: insights from the 2025 International Society of Amyloidosis Workshop
Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study
Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes
Guidelines for the management of hereditary ATTR amyloidosis 2026
Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment
Untwisted amyloid fibrils from a transgenic mouse model of AL amyloidosis
Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients
Medin and transthyretin: a new amyloid double act in the aortic wall and valves
Cold pressor test and paradoxical blood pressure reduction in light chain amyloidosis
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology
High rate of false negative 99m Tc-pyrophosphate scintigraphy scans in patients with Leu58His transthyretin amyloid cardiomyopathy
Men and women differ with regard to the prevalence, phenotype, and prognosis of wild-type transthyretin amyloid cardiomyopathy
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival
An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis
Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA)
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study
Clinical impact of beta-blocker withdrawal in transthyretin amyloid cardiomyopathy
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage
International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee
Incidence and predictors of sudden death in patients with cardiac amyloidosis
Jahrgänge
2026 · 752025 · 622024 · 612023 · 552022 · 442021 · 482020 · 482019 · 1352018 · 482017 · 1382016 · 412015 · 442014 · 472013 · 522012 · 762011 · 1352010 · 312009 · 452008 · 512007 · 522006 · 452005 · 442004 · 432003 · 562002 · 482001 · 412000 · 521999 · 531998 · 411997 · 411996 · 431995 · 481994 · 41
EUVIMED